Professor John Zalcberg was the Director, Division of Cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs Medicine, at the Peter MacCallum Cancer Centre in Melbourne, Australia for 17 years prior to recently taking up the position of Professor of Cancer Research in the School of Public Health and Preventive Medicine at Monash University. After earning a Bachelor of Medicine and Bachelor of Surgerytreatment involving removal of cancerous tissue and/or tumours and a margin of healthy tissue around it to reduce recurrence from the University of Melbourne and a PhD in cancer immunology, he served as Director of Medical Oncologythe study, diagnosis and treatment of cancer at the Heidelberg Repatriation Hospital and as Director of Cancer Services at the Austin and Repatriation Medical Centre.
A founder of the Lorne Cancer Conference and the Australasian Gastrointestinal Trials Group (AGITG), he is immediate past Chair of the Board of AGITG after serving in this role for over 15 years and a past Board Member of Cancer Trials Australia. He is the current Co-Chair of the Cancer Drugs Alliance and Interim Chair of the Australian Clinical Trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases Alliance.
A past Board Member of the NSW Cancer Institute, past President of the Clinical Oncological Society of Australia, and a past Member of the Consultative Council of the Victorian Cancer Agency, he has received a Medal of the Order of Australia Award (OAM) and the 2011 Cancer Achievement Award from the Medical Oncology Group of Australia.
Professor Zalcberg’s clinical research interests include gastrointestinal cancer and health care outcomes. He has published more than 230 articles in peer-reviewed journals. He was a Principal Investigator for the EORTC advancedat a late stage, far along GIST trial in Australia and continues an active involvement in trials in this disease as well as other GI cancers. He continues an active clinical practice in GI cancer.
Location
553 St Kilda Rd, Melbourne VIC, Australia
